SGHT Live signals | Maximize Profits with Getagraph.com

BUY 103289 min ago

@ $4.25

Issued: 13 Feb 2024 @ 09:30

Return: 32.17%

Previous signal: Feb 7 - 09:30

Previous signal: Sell

Return: -3.36 %

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases...

Stats
Today's Volume	83 677.00
Average Volume	174 830
Market Cap	278.49M
EPS	$0 ( 2024-03-07 )
Next earnings date	( $-0.290 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.93
ATR14	$0.0140 (0.25%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-03	Hayden Jeremy B.	Sell	4 893	Common Stock
2024-04-03	Badawi Paul	Sell	12 571	Common Stock
2024-04-03	Badawi David	Sell	3 128	Common Stock
2024-04-03	Park Sam Boong	Sell	3 414	Common Stock
2024-04-03	Bauerlein Alison	Sell	10 123	Common Stock

INSIDER POWER
-24.07
Last 95 transactions
Buy: 4 792 402 \| Sell: 8 805 650

Volume Correlation

Long: -0.28 (neutral)

Short: 1.00 (very strong)

Signal:(46.739) Expect same movement, but be aware

Sight Sciences, Inc. Correlation

10 Most Positive Correlations
COFS	0.925
LWAC	0.917
EM	0.911
STIM	0.903
PBYI	0.898
ESGR	0.888
RDVT	0.88
SDG	0.876
PPH	0.876
RVSB	0.873

10 Most Negative Correlations
PLMR	-0.903
SRZN	-0.898
MRUS	-0.882
NEXI	-0.881
PAYO	-0.868
MTSL	-0.867
PRVA	-0.863
IMRX	-0.86
SVAC	-0.858
FTOCU	-0.857

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sight Sciences, Inc. Correlation - Currency/Commodity

-0.59
( weak negative )

0.39
( neutral )

0.00
( neutral )

-0.72
( moderate negative )

0.29
( neutral )

0.65
( weak )

Sight Sciences, Inc. Financials

Annual	2023
Revenue:	$81.06M
Gross Profit:	$69.18M (85.34 %)
EPS:	$-1.140

Q4	2023
Revenue:	$18.75M
Gross Profit:	$15.98M (85.20 %)
EPS:	$-0.220

Q3	2023
Revenue:	$20.01M
Gross Profit:	$17.33M (86.62 %)
EPS:	$-0.270

Q2	2023
Revenue:	$23.47M
Gross Profit:	$20.09M (85.59 %)
EPS:	$-0.300

Financial Reports:

No articles found.

Sight Sciences, Inc.

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.